TipRanks
Advertisement
Advertisement
BioCryst price target lowered to $20 from $21 at Wedbush
PremiumThe FlyBioCryst price target lowered to $20 from $21 at Wedbush
2M ago
BioCryst price target lowered to $13 from $14 at RBC Capital
Premium
The Fly
BioCryst price target lowered to $13 from $14 at RBC Capital
2M ago
Stacy Ku Reiterates Buy on BioCryst, Citing Strong Orladeyo Momentum, Durable Growth, and Billion-Dollar HAE Opportunities
Premium
Ratings
Stacy Ku Reiterates Buy on BioCryst, Citing Strong Orladeyo Momentum, Durable Growth, and Billion-Dollar HAE Opportunities
2M ago
BioCryst resumed with a Neutral at JPMorgan
PremiumThe FlyBioCryst resumed with a Neutral at JPMorgan
2M ago
Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal
Premium
The Fly
Wedbush sees BioCryst, Ascendis as potential next targets after Crinetics deal
3M ago
BioCryst price target raised to $14 from $13 at RBC Capital
Premium
The Fly
BioCryst price target raised to $14 from $13 at RBC Capital
3M ago
BioCryst to discontinue internal discovery programs, close Alabama facility
PremiumThe FlyBioCryst to discontinue internal discovery programs, close Alabama facility
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
BioCryst Shareholders Approve Expanded Equity Incentive Plan
Premium
Company Announcements
BioCryst Shareholders Approve Expanded Equity Incentive Plan
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100